Aerie Pharmaceuticals Inc Banner Image

Aerie Pharmaceuticals Inc

  • Ticker AERI
    Exchange NASDAQ More
  • Industry Drug Manufacturers - Major More
  • Sector Healthcare More
Aerie Pharmaceuticals Inc Logo Image
  • 501-1000 Employees
  • Based in Durham, North Carolina
Aerie Pharmaceuticals, Inc., a clinical-stage pharmaceutical company, focuses on the discovery, development, and commercialization of first-in-class therapies for the treatment of glaucoma and other eye diseases. Its product candidates include Rhopressa, which is a once-daily eye drop that reduces intraocular pressure (IOP) in patients with glaucoma or ocular hypertension and is in PhaseMore III registration trials; and Roclatan, a once-daily eye drop to reduce IOP that has completed Phase IIb clinical trial in patients with open-angle glaucoma and ocular hypertension.
4.8 / 5.0 (96)

Aerie Pharmaceuticals Inc reports have an aggregate usefulness score of 4.8 based on 96 reviews.

Aerie Pharmaceuticals Inc

Most Recent Annual Report

Aerie Pharmaceuticals Inc
MOST RECENT 2021 Annual Report and Form 10K
Add Annual Report To Cart

Older/Archived Annual Reports

Aerie Pharmaceuticals Inc Logo Image

Rate This Report

Your vote helps our reports be more useful
Rating Saved!

Thank you for your feedback!